EUVIMEDEUVIMED entdecken
Crossref

Morin inhibited lung cancer cells viability, growth, and migration by suppressing miR-135b and inducing its target CCNG2

Dongjie Yao, Hujun Cui, Shufen Zhou, Ling Guo

Tumor Biology · 2017-10 · 39 (10) · 101042831771244

DOI: 10.1177/1010428317712443 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tumor Biology, online erschienen am 04.10.2017. Verfasst von Dongjie Yao und 3 weiteren Autor:innen. Beteiligte Einrichtung: 1 Department of Quality Control, Affiliated Second Hospital, Mudanjiang Medical University, Mudanjiang, China. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer is one of the most severe threats with the highest mortality rate to humans in the world. Recently, morin has been reported to have anti-tumor properties observed in several types of cancers. However, its mechanism is still unclear. We assessed the influences of morin on cell viability, colony formation, and migration ability of A549 and employed microRNA array to identify the microRNAs affected by morin. We found that morin-treated A549 cells showed statistically decreased cell viability, colony formation, and migration rate when comparing with the dimethyl sulfoxide-treated cells. Microarray results showed that with the treatment of morin, the expression level of miR-135b significantly reduced compared the control group, suggesting that morin may exert its anti-cancer property by suppressing the expression of miR-135b. In addition, we found a potential binding site of miR-135b within 3' untranslated region of CCNG2-encoding cyclin homolog cyclin-G2. We evidenced that miR-135b directly targets CCNG2, which could be a potential biomarker of lung cancer prognosis. Morin exerts its anti-tumor function via downregulating the expression of miR-135b that directly targets and represses CCNG2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

A549 CellsAntineoplastic AgentsAntioxidantsBlotting, WesternCarcinoma, Non-Small-Cell LungCell MovementCell ProliferationCell SurvivalCyclin G2FlavonoidsGene Expression Regulation, NeoplasticHumansKaplan-Meier EstimateLung NeoplasmsMicroRNAsOligonucleotide Array Sequence AnalysisPolymerase Chain ReactionFlavones

Stichwörter der Autor:innen

Morincyclin homolog cyclin-G2lung cancermiR-135b

Substanzen

Antineoplastic AgentsAntioxidantsCyclin G2FlavonoidsMicroRNAsCCNG2 protein, humanMIRN135 microRNA, humanmorinFlavones

Autor:innen und Institutionen

  • 1 Department of Quality Control, Affiliated Second Hospital, Mudanjiang Medical University, Mudanjiang, China.
  • 2 Department of Oncology, Affiliated Hongqi Hospital, Mudanjiang Medical University, Mudanjiang, China.
  • 3 Department of Gerontology, Affiliated Second Hospital, Mudanjiang Medical University, Mudanjiang, China.
  • 4 Department of Pathology, Affiliated Second Hospital, Mudanjiang Medical University, Mudanjiang, China.

Zitieren

APA

Yao, D., Cui, H., Zhou, S., & Guo, L. (2017). Morin inhibited lung cancer cells viability, growth, and migration by suppressing miR-135b and inducing its target CCNG2. Tumor Biology, 39(10), 101042831771244. https://doi.org/10.1177/1010428317712443

Vancouver

Yao D, Cui H, Zhou S, Guo L. Morin inhibited lung cancer cells viability, growth, and migration by suppressing miR-135b and inducing its target CCNG2. Tumor Biology. 2017;39(10):101042831771244. doi:10.1177/1010428317712443

BibTeX
@article{Yao2017,
  author = {Yao, Dongjie and Cui, Hujun and Zhou, Shufen and Guo, Ling},
  title = {Morin inhibited lung cancer cells viability, growth, and migration by suppressing miR-135b and inducing its target CCNG2},
  journal = {Tumor Biology},
  year = {2017},
  volume = {39},
  number = {10},
  pages = {101042831771244},
  doi = {10.1177/1010428317712443}
}
Kostenlos starten →